You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

SODIUM IODIDE I 131 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Sodium Iodide I 131, and what generic alternatives are available?

Sodium Iodide I 131 is a drug marketed by CIS, Curium, Jubilant, and Intl Isotopes. and is included in six NDAs.

The generic ingredient in SODIUM IODIDE I 131 is sodium iodide i-131. There are one thousand four hundred and seventy-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the sodium iodide i-131 profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SODIUM IODIDE I 131?
  • What are the global sales for SODIUM IODIDE I 131?
  • What is Average Wholesale Price for SODIUM IODIDE I 131?
Drug patent expirations by year for SODIUM IODIDE I 131
Recent Clinical Trials for SODIUM IODIDE I 131

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Health Network, TorontoPhase 4
Stryker EndoscopyPhase 4
Osaka UniversityPhase 1

See all SODIUM IODIDE I 131 clinical trials

Pharmacology for SODIUM IODIDE I 131

US Patents and Regulatory Information for SODIUM IODIDE I 131

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cis SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 017316-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Jubilant SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 021305-004 Nov 18, 2004 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Curium SODIUM IODIDE I 131 sodium iodide i-131 CAPSULE;ORAL 016517-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.